Shire BioChem inc.

Shire BioChem inc.

Shire Pharmaceuticals Group plc (Shire) is a global pharmaceutical company with a strategic focus on meeting the needs of the specialist physician and currently focuses on developing projects and marketing products in the areas of central nervous system (CNS), gastrointestinal (GI), and renal diseases. Shire has operations in the worlds key pharmaceutical markets (US, Canada, UK, France, Italy, Spain
and Germany) as well as a specialist drug delivery unit in the US.

Company Details

Year Established: 1986

Total Sales ($CDN): $25,000,000 - $50,000,000

Number of Employees: 75

Company Information

Michel Florio
Title: Directeur des Ventes
Telephone: (514) 787-2300
Fax: (514) 787-2427
Email: Click Here

Products

3tc, Epivir, Combivir, Trizivir

Agrylin
Agrylin has been introduced in Canada in 1998 for the treatment of essential thrombocythaemia, a chronic disorder associated with increased or abnormal production of blood platelets.

Heptovir
Lamivudine has also been shown to be effective in treating patients with chronic Hepatatis B infection and is available as HEPTOVIR for this indication. In an agreement similar to that for lamivudine in HIV/AIDS, Shire receives royalties on sales, except in Canada where we have a business partnership with GSK.

Alertec
Wake promoting agent in narcolepsy

Hectorol
Vitamin D analog for the treatment of secondary hyperparathyroidism in patients undergoing dialysis.

Permax
PERMAX (pergolide mesylate), a synthetic ergot derivative, is a dopamine receptor agonist at both D1 and D2 receptor sites. PERMAX (pergolide mesylate) is indicated in the treatment of the signs and symptoms of idiopathic Parkinsons disease. PERMAX (pergolide mesylate) may be used both as early therapy, without concomitant levodopa, and as an adjunct to levodopa (usually with a peripheral decarboxylase inhibitor).

Zanaflex
ZANAFLEX (tizanidine hydrochloride) is an agonist at 2-adrenergic receptor sites and presumably reduces spasticity by increasing presynaptic inhibition of motor neurons. ZANAFLEX (tizanidine hydrochloride) is a short-acting drug for the management of spasticity.

Services